Objective. Lidocaine alleviates propofol injection pain. However, whether lidocaine works through a local anesthetic effect at the site of intravenous injection or through a systemic effect on the central nervous system remains unknown. This study aimed to determine the pain-alleviating mechanism of lidocaine.
Introduction
Propofol is a rapid and efficient general anesthetic that has been widely used. However, the pain following an injection of propofol remains an issue; it was ranked seventh of 33 identified clinical issues by anesthesiologists who classified clinical anesthetic outcomes [1] . Patients who experience pain may suffer from anxiety, fear, boredom, and even myocardial ischemia and infarction [2] . The pain may therefore decrease patient satisfaction and safety. Previous studies have reported the incidence of pain at 28% to 90% [3] . Many patients complained that the pain was intense, and some patients even stated that the pain was the most unbearable experience during the perioperation [4] . A large number of studies have reported that various factors alleviate the injection pain, including the use of mediumto-long chain triglycerides, emulsified propofol, venous occlusion, a small dose of opioids (e.g., sufentanil and butorphanol) [5, 6] , injections of large veins, the addition of lidocaine with a tourniquet [7] , cooling or warming the propofol [8] , diluting the propofol solution, prior injection of metoclopramide [9] , magnesium [10] or a b-blocker [11] , midazolam to erase the memory of vascular pain during the propofol administration [12] , 5-HT3 receptor antagonists [13] , and the a-2 adrenoceptor agonist dexmedetomidine [3] . Overall, one of the most effective factors involves pretreatment with lidocaine [14] .
Lidocaine is a commonly used local anesthetic that acts locally and systemically. Intravenous lidocaine can reduce cancer pain, neuropathic pain, pain after surgery, and the refractory complex regional pain syndrome [15] [16] [17] [18] [19] [20] . In previous studies, several dosages of lidocaine reduced the injection pain of propofol. However, the mechanism by which this occurs remains unknown. In addition, it is not known if different dosages of lidocaine act through different mechanisms. We therefore designed studies wherein lidocaine was administered either through the same vein as propofol or through a symmetric vein of the other hand to investigate whether lidocaine primarily acted as a local anesthetic or in a systemic capacity to reduce pain.
Methods
After approval of the Hospital Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University and registration on the Chinese Clinical Trial Registry (ethical code: ChiCTR-IOR-15006006), patients age 18 to 60 years who were American Society of Anesthesiologists (ASA) class I to II and were scheduled for elective painless gastroscopy were included in the study. All patients signed an informed written consent form. Patients were excluded if they had a history of drug abuse, chronic use of any medication, the presence of neurological or psychiatric disorders, uncontrolled hypertension, or renal or hepatic insufficiency. Patients were also excluded if they had a known history of hypersensitivity to the study drugs.
All patients were withheld analgesics or sedatives the day before the surgery. During their scheduled surgery, a 24-gauge cannula was inserted into the largest vein of the right or left hand of the patient and connected to a T-connector for drug administration. Standard ASA monitors were attached to monitor noninvasive arterial pressure, electrocardiography, and pulse oximetry levels.
The study was divided into two parts. Part 1 determined the effects of low-dosage lidocaine using 20 mg and 40 mg according to a previous study [21] . A total of 717 patients were randomly allocated into five groups using a randomly generated table: Group PR (placebo) received 2 mL of normal saline injected intravenously via the largest dorsal vein of the right hand. Group RL20 received 20 mg of lidocaine injected intravenously via the largest dorsal vein of the right hand. Group RL40 received 40 mg of lidocaine injected intravenously via the largest dorsal vein of the right hand. Group LL20 received 20 mg lidocaine injected intravenously via the largest vein of the left dorsal hand. Group LL40 received 40 mg of lidocaine injected intravenously via the largest dorsal vein of the left hand. Part 2 determined the effects of high-dosage lidocaine. We chose 1.2 mg/kg and 1.5 mg/kg according to a previous study [22] . A total of 378 patients were randomly assigned to five groups. Group RL40 received 40 mg of lidocaine injected intravenously via the largest dorsal vein of the right hand. Group RL1.2 received 1.2 mg/kg of lidocaine injected intravenously via the largest dorsal vein of the right hand. Group LL1.2 received 1.2 mg/kg of lidocaine injected intravenously via the largest dorsal vein of the left hand. Group RL1.5 received 1.5 mg/kg of lidocaine injected intravenously via the largest dorsal vein of the right hand. Group LL1.5 received 1.5 mg/kg of lidocaine injected intravenously via the largest dorsal vein of the left hand. Two minutes later, all groups received intravenous injections of 2 mg/kg propofol via the largest dorsal vein of the right hand. The injection pain was evaluated when 25% of the total propofol dosage was administered. Fentanyl (50 lg) and the remaining propofol were then administered. The mean arterial pressure, heart rate, incidence of injection pain, verbal rating scale scores, patient satisfaction, and postoperative nausea and vomiting were also recorded.
All study medications were prepared in 10 mL syringes covered with black tape by an anesthesiologist who was not involved in the study. All study drugs were maintained at room temperature and were used within 20 minutes after preparation. Another anesthesiologist, who was blinded to the group assignments, assessed the intensity of pain after propofol injections. The assessing anesthesiologist used the visual rating scale (VRS) score to evaluate the level of the pain, from the time of propofol injection to the loss of consciousness. Pain was graded on a scale of 0 to 3 (0 ¼ no pain; 1 ¼ slight pain; 2 ¼ moderate pain; and 3 ¼ severe pain), with a score of 1 or higher considered unacceptable. The mean arterial pressure (MAP) and heart rate (HR) were recorded immediately prior to the injection of the drug and then every five minutes until the propofol injection. All patients received 2 mg/kg of 1% propofol (Astra-Zeneca, Macclesfield, UK) at a rate of 20 mL/minute. The patient satisfaction, time of anesthesia and discharge, and the incidence of complications were recorded.
Statistical Analyses
Statistical analyses were performed using SPSS statistical software for Windows, version 13.0 (SPSS, Chicago, IL, USA). The ages and weights were expressed as the mean 6 standard deviation and compared using oneway analysis of variance. The VRS was compared using the Kruskal-Wallis test. Categorical data such as sex, ASA status, and the number of patients reporting pain scores of 1 or higher were expressed as numbers, percentages, or both and were compared using the chisquare test or Fischer's exact test as appropriate. Corrected P values of less than 0.05 were considered significant.
Results

Part 1
Demographic and Clinical Characteristics of Patients
During the period from August 2014 to February 2015, 1,529 patients underwent painless gastroscopy. Among them, 575 patients did not meet the inclusion criteria and 207 patients refused to take part in the study and were excluded. A total of 717 patients completed the study in part 1 ( Figure 1 ).
There was no significant difference among groups with respect to age, weight, body mass index, sex, or ASA class (P > 0.05) ( Table 1 ).
The administration of 40 mg of lidocaine through the largest dorsal vein of one hand did not alleviate the pain of the other hand injected with propofol, but it did reduce the pain of injection in the same vein.
The incidence of injection pain (VRS score 1) of group RL40 was significantly lower than that of group PR. There was no difference among the other groups. The incidence of pain in each group was as follows: group PR, 82.3%; group RL20, 73.3%; group RL40, 56.7%; group LL20, 79.4%; and group LL40, 79.6% ( Figure 2 ).
Patient Satisfaction of All Groups
The patient satisfaction of group RL40 was significantly higher than that of group PR. There was no difference among the other groups. The patient satisfaction in each group was as follows: group PR, 56.5%; group RL20, 65.8%; group RL40, 75.9%; group LL20, 61.0%; and group LL40, 61.3% (Figure 3 ).
The Times of Anesthesia, Discharge, Gastroscopy, and Total Dosage of Propofol No difference was found among all groups with regard to the total dosage of propofol and the times of anesthesia, discharge, and gastroscopy. The patient satisfaction of group RL40 was significantly higher than that of group PR. There was no difference among the other groups. *P < 0.005 when compared with group PR. The number in the white box stands for the percentage of patients who expressed their satisfaction.
Adverse Events
There was little or no change in the MAP and HR during the perioperation. We administered 0.3 mg of atropine when the HR dropped below 50 times per minute and 1 mg of dopamine when the MAP dropped below 60 mmHg. The dosing of drugs was repeated when needed. No difference was found among all groups with regard to bradycardia, hypotension, the use of atropine and dopamine, or other complications.
Part 2
Demographic and Clinical Characteristics of the Patients
During the period from February 2016 to April 2016, 624 patients underwent painless gastroscopy. Among them, 182 patients did not meet the inclusion criteria and 30 patients refused to take part in the study. All were excluded from the study. Overall, 378 patients completed the part 2 study (Figure 4 ).
There was no significant difference among groups with respect to age, weight, body mass index, sex, or ASA class (P > 0.05) ( Table 2 ).
Lidocaine administered through the largest dorsal vein of one hand alleviated the pain of the other hand in which propofol was injected when the dosage reached 1.5 mg/kg.
The incidence of injection pain of group LL1.2 was significantly higher than that of the other groups. The incidences of injection pain of groups LL1.5 and RL1.5 were significantly lower than that of group PR40. The incidence of pain in each group was as follows: group LL1.5, 39.3%; group RL1.5, 39.7%; group LL1.2, 82.9%; group RL1.2, 54.7%; and group RL40, 63.1% ( Figure 5 ).
Patient Satisfaction of All Groups
The patient satisfaction of group LL1.2 was significantly lower than that of the other groups. There was no difference among the other groups. The patient satisfaction in each group was as follows: group LL1.5, 70.1%; group RL1.5, 72.5%; group LL1.2, 54.2%; group RL1.2, 65.8%; and group RL40, 65.5% ( Figure 6 ).
The Times of Anesthesia, Discharge, Gastroscopy, and Total Dosage of Propofol
The total dosage of propofol in group LL1.5 and group RL1.5 was less than that of group RL40 (Figure 7) . No difference was found among all groups with regard to the times of anesthesia, discharge, and gastroscopy.
Adverse Events
No difference was found among all groups with regard to bradycardia, hypotension, the use of atropine and dopamine, or other complications. More patients in groups LL1.5 and RL1.5 complained of tinnitus or dizziness (Table 3) .
Discussion
Injection pain is thought to be associated with a high aqueous free propofol concentration [23] . One mechanism postulates that dissociated propofol crosses the blood vessel and stimulates nociceptive receptors or nerve ending (i.e., the injection pain is locally induced). However, Nakane et al. suggested that dissociated propofol activates the plasma kallikrein-kinin system that releases bradykinin and causes pain (i.e., the injection pain is systemically induced) [24] . Depending on the above mechanisms, lidocaine (a local anesthetic); dexmedetomidine, tramadol, and ketamine (central analgesics); remifentanil (a type of opioid); and flurbiprofen (a type of a nonsteroidal anti-inflammatory drug) can alleviate propofol injection pain to a limited extent [25] [26] [27] [28] [29] [30] .
Although a local anesthetic, lidocaine can also act in a systemic manner [31] . Several mechanisms of antinociception have been proposed for low-dose systemic lidocaine, including actions on C-afferent neuronal activity [32] , actions in the spinal dorsal horn [33] , reductions of There were no significant differences among the five groups with respect to age, weight, height, sex, or ASA class (P > 0.05). ASA ¼ American Society of Anesthesiologists. Figure 5 Visual rating scale score in part 2. The incidence of injection pain of group LL1.2 was significantly higher than that of the other groups. The incidences of injection pain of groups LL1.5 and RL1.5 were significantly lower than that of group PR40. *P < 0.005 when compared with group RL40; † P < 0.005 when compared with group LL1.2. The number in the white box stands for the percentage of patients who complained of injection pain. the postsynaptic depolarization mediated by N-methyl-D-aspartate receptors [34] , and blocking peripheral and central voltage-gated sodium channels in the dorsal root ganglion [35] . Intravenous lidocaine may also have antinociceptive actions by inhibiting several inflammatory activities, including p38 MAPK and NF-kB signaling pathways, and toxic oxygen-free radical production [36, 37] . Considering that the systemic effects of propofol, which could activate the plasma kallikrein-kinin system, may also cause injection pain, it is also possible that lidocaine alleviates pain by inhibiting the systemic effects of propofol. There is no study that illuminates whether intravenous lidocaine alleviates the pain of propofol injection by local anesthetic or central analgesic effects. Then the objective of this study was therefore to determine whether lidocaine primarily acted as a local anesthetic or in a systemic capacity to reduce pain.
Patients in four groups (groups LL20 and LL40 in part 1 and groups LL1.2 and LL1.5 in part 2) received intravenous injections of lidocaine via the largest dorsal vein of the left hand and propofol via the largest dorsal vein of the right hand. In this manner, propofol and lidocaine were administered via remote veins. We found that lidocaine had little or no local anesthetic effect on the vein of the right hand through which the propofol was injected. The effect of lidocaine takes approximately 20 to 40 seconds to reach the cerebrum from the dorsum of the hand. In our study, lidocaine was injected two minutes prior to the injection of propofol, which provided sufficient time for lidocaine to circulate from the hands to the central nervous system.
In the low-dosage groups, 20 mg of lidocaine did not reduce the pain of both hands, while 40 mg of lidocaine alleviated the pain within the same vein in which propofol was injected. We therefore determined whether 40 mg of lidocaine reduced propofol injection pain within the same vein, primarily by a local anesthetic effect. In the high-dosage groups, 1.2 mg/kg of lidocaine did not reduce the pain of the contralateral hand in which propofol was injected. We then determined whether 1.2 mg/kg of lidocaine also reduced propofol injection pain within the same vein, primarily by a local anesthetic effect. We found that 1.5 mg/kg of lidocaine reduced the pain of the same hand and also the contralateral hand in which propofol was injected. A dosage of Figure 6 Patient satisfaction in part 2. The patient satisfaction of group LL1.2 was significantly lower than that of the other groups. There was no difference among the other groups. *P < 0.005 when compared with group RL40. The number in the white box stands for the percentage of patients who expressed their satisfaction . Figure 7 The total dosage of propofol in part 2. The total dosage of propofol in group LL1.5 and group RL1.5 was less than that of group RL40. No difference was found among all groups with regard to the times of anesthesia, discharge, and gastroscopy. *P < 0.05 when compared with group LL1.5.
15 mg/kg of propofol was also injected, showing that 1.5 mg/kg of lidocaine reduced the pain by both a local anesthetic and the central anesthetic effect. However, more patients complained of tinnitus or dizziness after the injection of 1.5 mg/kg of lidocaine that lasted a few minutes, which was acceptable in comparison with the local irritating effects of propofol, and none of the patients experienced discomfort when they were removed from anesthesia.
The total dosage of propofol in groups LL1.5 and RL1.5 was less than that of group RL40, and the high dosage of lidocaine reduced the total dosage of propofol. A previous study reported that there was no significant reduction in propofol requirements after the administration of 0.5 mg/kg of lidocaine; however, an intravenous bolus injection of 1.5 mg/kg of 2% lidocaine caused a significant reduction of the plasma concentration of propofol, which is required to prevent a movement response in 50% of patients during a surgical incision [22] . These results are consistent with our observations. Additionally, no difference was observed among all groups with respect to the times of anesthesia, discharge, gastroscopy, and the incidences of complications. Kranke et al. reported that the incidences of complications and delayed emergence from anesthesia significantly increased when the dosage of lidocaine was greater than 3 mg/kg [38] . These conditions were not used in our study, but they may be the reason for the fewer complications that were observed.
Kim reported that a combination of lidocaine and propofol reduced injection pain within a dosage range of 20 to 40 mg and that increasing the lidocaine dosage significantly reduced pain during the injection of propofol [39] . Another study reported that a 10 mg mixture of propofol and lidocaine reduced injection pain and had the same effect as the administration of 1 mg/kg of lidocaine 30 seconds before the administration of propofol [40] . However, because the effect of lidocaine on propofol emulsion stability is unstable over time and may cause pulmonary embolism, we did not recommend the administration of a mixture of the drugs [41, 42] .
The total dose and injection rate of propofol were 2 mg/ kg and 20 mL/minute, respectively, in our study. The HR and MAP marginally declined during the surgery but were corrected with atropine and dopamine, respectively. Thus, the total dose and injection rate of propofol were safe and effective.
Limitations
There were few, if any, limitations in our study. We could not study the administration of lidocaine at 2 or more mg/kg due to ethical restrictions. According to previous studies, lidocaine is considered one of the most useful drugs to alleviate injection pain [24] . Kim et al. [43] administered different doses of lidocaine (40 mg, 60 mg, and 80 mg) and found that 60 mg lidocaine was the minimum dose required to reduce pain. Alipour et al. [21] reported that 40 mg lidocaine was sufficient to relieve injection pain, which is consistent with the results of our study. However, we did not measure the plasma concentrations of lidocaine.
Conclusions
A dosage of 40 mg lidocaine is an appropriate dosage to alleviate propofol injection pain within the same vein. Lidocaine reduces propofol injection pain through both a local anesthetic effect and a central analgesic effect when the dosage reaches 1.5 mg/kg. 
